Stimulants like Adderall and Ritalin are the most commonly prescribed ADHD medications but they’re not right for everyone. Some people experience intolerable side effects. Others have a history that makes stimulant use inadvisable. Others simply prefer a non-controlled option. And for some, non-stimulants work better.

Non-stimulant ADHD medications are not a second-choice fallback. For the right person, they’re the right first choice. Here’s everything you need to know.

What Are Non-Stimulant ADHD Medications?

Non-stimulant ADHD medications treat the core symptoms of ADHD — inattention, hyperactivity, and impulsivity — without using amphetamines or methylphenidate (the active compounds in stimulant medications).

They work through different neurochemical pathways, primarily targeting norepinephrine rather than dopamine. This produces a more gradual, sustained effect rather than the faster, more pronounced response associated with stimulants.

There are FDA-approved non-stimulant options as well as medications commonly used off-label. Understanding the difference matters when discussing options with your provider.

The Main Non-Stimulant Options

Strattera (Atomoxetine)

Strattera was the first non-stimulant medication specifically approved by the FDA for ADHD in both adults and children (ages 6 and up). It works as a selective norepinephrine reuptake inhibitor (SNRI), increasing the availability of norepinephrine in the prefrontal cortex — the region most responsible for attention, impulse control, and working memory.

• Onset: Full effect typically takes 4–8 weeks — significantly longer than stimulants, which work the same day
• Dosing: Once or twice daily; does not need to be taken at a specific time relative to activity
• Common side effects: Decreased appetite, nausea, fatigue (especially early), mood changes, and in adults, potential sexual side effects
• A key advantage: No abuse potential; not a controlled substance

Qelbree (Viloxazine)

Qelbree is the newest FDA-approved non-stimulant for ADHD (approved 2021 for children; 2022 for adults). It works as a serotonin-norepinephrine modulating agent — a slightly different mechanism from Strattera — and some patients report faster onset.

• Onset: Some patients notice improvement within 1–2 weeks, though full effect still takes several weeks
• Dosing: Once daily, extended-release capsule
• Common side effects: Somnolence, decreased appetite, irritability, nausea
• Note: Most clinical data is in pediatric and adolescent populations; adult data is more limited

Intuniv / Kapvay (Guanfacine / Clonidine)

These alpha-2 adrenergic agonists were originally developed as blood pressure medications. At lower doses, they act on receptors in the prefrontal cortex to improve attention and reduce hyperactivity and impulsivity — particularly emotional impulsivity, which stimulants sometimes address less effectively.

• Best for: ADHD with prominent hyperactivity, emotional dysregulation, or co-occurring anxiety — where stimulants may worsen anxiety
• Often used as: An adjunct to stimulant medication rather than a standalone
• Common side effects: Sedation, low blood pressure, dizziness — especially at initiation
• Important: Should not be stopped abruptly; requires gradual tapering

Wellbutrin (Bupropion) — Off-Label

Bupropion is an antidepressant that inhibits the reuptake of both norepinephrine and dopamine — a mechanism that also improves ADHD symptoms in many people. It is not FDA-approved for ADHD but is widely used off-label, particularly in adults.

• Best for: Adults with ADHD and co-occurring depression or those who have not responded to approved options
• Onset: Several weeks for full effect
• Common side effects: Insomnia, dry mouth, increased blood pressure, reduced seizure threshold at high doses
• Important note: Not appropriate for individuals with a history of eating disorders or seizure disorders

Who Should Consider Non-Stimulant ADHD Medication?

Non-stimulants are often the most appropriate choice — or the preferred first choice — for people who:

• Have a personal or family history of substance use disorder
• Experience stimulant-induced anxiety, racing heart, insomnia, or mood swings
• Have co-occurring anxiety disorders that stimulants worsen
• Prefer a non-controlled medication (for occupational, legal, or personal reasons)
• Are children with tic disorders — stimulants can exacerbate tics in some cases
• Have cardiovascular conditions that make stimulants medically inadvisable

It’s also worth noting that “stimulant didn’t work” is not the same as “ADHD medication doesn’t work.” Many people who had poor or partial responses to stimulants respond well to non-stimulants, and vice versa.

Stimulant vs. Non-Stimulant: How Providers Decide

There’s no universal algorithm. The decision is individualized based on medical history, co-occurring conditions, lifestyle, and personal preference. In general:

• Stimulants tend to produce faster, more pronounced symptom reduction for most people
• Non-stimulants often have a more favorable side-effect profile for long-term use
• Neither approach is categorically superior — the right choice depends on the individual

One significant advance in this decision-making process is pharmacogenomic (genetic) testing. By analyzing specific genetic variants — particularly in enzymes that metabolize psychiatric medications — providers can predict which medications are likely to work well, which are likely to cause side effects, and which to avoid entirely. This takes much of the trial-and-error out of the process.

At California Healing Centers, genetic testing is integrated into our medication management program as a standard part of the psychiatric evaluation process.

What to Expect When Starting a Non-Stimulant

The most important thing to know before starting a non-stimulant is this: patience is required. Unlike stimulants — which work within hours — non-stimulants require consistent daily dosing over weeks before their full benefit is apparent.

• Week 1–2: Possible side effects (nausea, fatigue, appetite changes); minimal symptom improvement in most cases
• Week 3–4: Side effects typically diminish; some symptom improvement may begin
• Week 6–8: Full therapeutic effect in most cases

Regular follow-up with your prescriber during this period is essential. Doses are typically titrated upward gradually to minimize side effects and find the optimal therapeutic dose.

Can Non-Stimulant Medication Be Part of a Broader Treatment Plan?

Yes — and it should be. Medication alone, whether stimulant or non-stimulant, addresses the neurochemical component of ADHD but not the behavioral, emotional, and relational patterns that develop alongside it.

Comprehensive ADHD treatment typically combines medication with:

• Cognitive Behavioral Therapy (CBT): Builds practical executive function skills and addresses the chronic shame and self-criticism that commonly develop with ADHD
• Individual therapy: Works through relationship patterns, emotional dysregulation, and the deeper impact of years of unmanaged symptoms
• Psychoeducation: Understanding how ADHD actually works changes how people relate to their own symptoms

When ADHD is severe, co-occurring with other conditions, or has been inadequately treated for years, a residential setting allows for intensive, integrated care — medication management, therapy, and daily structure in a supportive environment — that outpatient treatment can’t replicate.

Finding the Right Fit Takes Real Support

Finding the right ADHD medication is rarely straightforward. It takes proper psychiatric evaluation, close monitoring, and often several adjustments before the right fit is found. At California Healing Centers, our psychiatric team uses genetic testing alongside comprehensive evaluation to take the guesswork out of medication selection — so you spend less time cycling through options and more time actually getting better.

If you’re struggling to find what works — or if ADHD is significantly affecting your quality of life — we’re here to help. Reach out to our team or verify your insurance to get started.